Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab

Annals of the Rheumatic Diseases

Volumn 70, Issue 6, 2011, Pages 1164-1165

  Ogata, Atsushi ^a   Morishima, Atsuyoshi ^a   Hirano, Toru ^a   Hishitani, Yoshihiro ^a   Hagihara, Keisuke ^a   Shima, Yoshihito ^a   Narazaki, Masashi ^a   Tanaka, Toshio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; PREDNISOLONE; TOCILIZUMAB;

CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DRUG DOSE REDUCTION; HUMAN; HYPOGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SYNTHESIS; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; TREATMENT DURATION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; RECEPTORS, INTERLEUKIN-6;

EID: 79955807238     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.132845     Document Type: Letter

References (7)

1. Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 2008;14:222-31. (Pubitemid 351481853) (Pubitemid 351481853)
2. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34. (Pubitemid 32656163) (Pubitemid 32656163)
3. Fève B, Bastard JP. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 2009;5:305-11.
4. Kawazoe Y, Naka T, Fujimoto M, et al. Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J Exp Med 2001;193:263-9. (Pubitemid 32524458) (Pubitemid 32524458)
5. Tam LS, Tomlinson B, Chu TT, et al. Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol 2007;26:1495-8. (Pubitemid 47201685) (Pubitemid 47201685)
6. Araújo EP, De Souza CT, Ueno M, et al. Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes. Endocrinology 2007;148:5991-7. (Pubitemid 350146162) (Pubitemid 350146162)
7. Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356:1517-26. (Pubitemid 46588416) (Pubitemid 46588416)